- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01011803
Correlation of Phonation With Deglutition and Aspiration Risk in the ICU Patients - an Exploratory Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aspiration is defined as entry of a solid or liquid material into the respiratory tract, below the vocal folds, or inhalation of fumes and vapors. Aspiration pneumonia is an infectious process caused by aspirated oropharyngeal flora, while aspiration pneumonitis is caused by a direct chemical insult due to the aspirated material.
Aspiration pneumonitis and pneumonia among hospitalized patients result in increased morbidity, mortality and utilization of resources, with increased costs of care. Early identification of patients at risk for aspiration is crucial to prevent this preventable and often iatrogenic condition.
In general, the most common predisposing factors for aspiration in adults are alcoholism, stroke, neuromuscular disorders, seizures, and loss of consciousness, and these patients are usually cared for in the ICU setting. Furthermore, critically ill patients are also at risk as they are frequently under varying degrees of sedation, especially early in the post extubation period. Postoperative patients in addition may have prolonged functional dysphagia due to lingering effect of neuromuscular blocking agents. However, risks of aspiration may apply to any hospitalized patient and further studies with broader inclusion criteria will be needed based on the preliminary results of this pilot study.
There are multiple tools to assess for risk of aspiration in the ICU. These include Dysphagia Admission Screening Tool (DAST), Fiberoptic Endoscopic Evaluation of the Swallow (FEES) and Modified Barium Swallow (MBS), which are routinely performed at our institution. The DAST is relatively novel screening tool, brought up as an early method for identification of dysphagia, as mandated by Joint Commission. This test has not been yet validated. It was created in 2004 in order to reduce the risk of aspiration among new stroke patients, based upon literature review, research and a strong foundation of knowledge and experience in Speech-Language Pathology in evaluating dysphagia. The FEES and MBS are time consuming, often delayed and involve advanced testing that is performed by a certified speech-language pathologist and/or radiologist. MBS also requires transport of the patient from the ICU to the radiology suite and back. These tests examine function of swallow mechanism in order to predict individual patient's risk of aspiration. They are reported as pass or fail and graded from 1-8, depending on the degree of the bolus penetration into the airway and/or expulsion from the airway. The current "gold standard" to determine the risk of aspiration is considered to be MBS.
We hypothesize that among critically ill, impairments in phonation correlate significantly to impairments in deglutition. Since in current practice patient's risk for aspiration is judged based on swallowing ability, strong correlation between impairments in speech and swallow mechanisms may allow prognostication based on phonation assessment alone. As the phonetic evaluation is simple, bedside test, it may result in earlier identification of the patient at risk for aspiration and obviate need for additional, invasive and expensive tests, and additional staff utilization for patient transport, testing and interpretation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients admitted to the ICU, deemed at risk for aspiration, who require FEES and MBS per speech therapy evaluation.
- Ability to follow commands, read English language, vocalize and complete a predefined phonation test and the DAST.
- Patients are able to undergo formal swallow evaluation by FEES and/or MBS.
Exclusion Criteria:
- Patients who have had any type of head and neck surgery.
- Patients that cannot read or talk, or speak/understand English language.
- Patients with delirium, disorientation, unable to follow commands.
- Patients with gastric tubes, tracheostomy or strict order for nothing by mouth.
- Coagulation disorder that is prohibitive for FEES (platelets <50, 000, ongoing or uncontrolled bleeding, international normalized ratio (INR)> 1.5, activated partial thromboplastin time (aPTT) greater than 1.5 times normal value).
- Patients that cannot sit up at 90 degrees for MBS.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Combined speech therapy tools, measures of swallowing function
All subjects will be assessed using combined speech therapy tools and ordinal measures of swallowing function.
The combined speech therapy tools were [diadochokinesis, glottal coup, and the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)].
The ordinal measures of swallowing function included Dysphagia Admission Screening Tool (DAST), Modified Barium Swallow (MBS), and Fiberoptic Endoscopic Evaluation of the Swallow (FEES).
|
All subjects will be assessed using combined speech therapy tools and ordinal measures of swallowing function.
The combined speech therapy tools were [diadochokinesis, glottal coup, and the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)].
The ordinal measures of swallowing function included Dysphagia Admission Screening Tool (DAST), Modified Barium Swallow (MBS), and Fiberoptic Endoscopic Evaluation of the Swallow (FEES).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ability of combined speech score to predict moderate to severe MBS/FEES Dysphagia
Time Frame: 24 hours
|
Associations between measures of speech functions and ordinal measures of swallowing function will be examined by estimating Pearson's correlation coefficient.
Categorical variables will be summarized with number and percentage.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ability of each individual speech score to predict MBS/FEES Dysphagia
Time Frame: 24 hours
|
Associations between measures of speech functions and ordinal measures of swallowing function will be examined by estimating Pearson's correlation coefficient.
Categorical variables will be summarized with number and percentage.
|
24 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 09-004079-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aspiration
-
Augusta UniversityCompletedEvaluation of the Effect of Body Mass Index on Gastric Volume With Ultrasound in Term Pregnant WomenPregnancy Related | Airway Aspiration | AspirationUnited States
-
Brasilia University HospitalUnknownFasting | Aspiration; Liquids | Perioperative Pulmonary AspirationBrazil
-
University of North Carolina, Chapel HillCompletedAspirationUnited States
-
Seoul National University HospitalUnknown
-
University Health Network, TorontoCompleted
-
Connecticut Children's Medical CenterEnrolling by invitation
-
Hospital San Carlos, MadridCompleted
-
Procare Riaya HospitalUnknown
-
Procare Riaya HospitalCompletedAspirationSaudi Arabia
-
Procare Riaya HospitalUnknownASPIRATIONSaudi Arabia
Clinical Trials on Combined speech therapy tools, measures of swallowing function
-
National Taiwan University HospitalEnrolling by invitationDysphagia RehabilitationTaiwan
-
NRG OncologyNational Cancer Institute (NCI)RecruitingBreast CancerUnited States, Canada, Puerto Rico, Japan, Mexico, Peru, Uruguay, Colombia
-
Mayo ClinicWithdrawnHead and Neck Carcinoma | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IV Hypopharyngeal Carcinoma AJCC v8 | Stage IV Laryngeal Cancer AJCC v8 | Stage... and other conditions
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruitingBreast CancerUnited States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States